Nancy Paz

658 total citations
21 papers, 539 citations indexed

About

Nancy Paz is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Nancy Paz has authored 21 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Biomedical Engineering and 9 papers in Oncology. Recurrent topics in Nancy Paz's work include Cancer therapeutics and mechanisms (10 papers), Nanoplatforms for cancer theranostics (10 papers) and Nanoparticle-Based Drug Delivery (9 papers). Nancy Paz is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Nanoplatforms for cancer theranostics (10 papers) and Nanoparticle-Based Drug Delivery (9 papers). Nancy Paz collaborates with scholars based in United States, Canada and United Kingdom. Nancy Paz's co-authors include Jonathan B. Fitzgerald, Ashish Kalra, Daryl C. Drummond, Stephan G. Klinz, Jaeyeon Kim, Ulrik B. Nielsen, Jason E. Cain, Helen Lee, Narasimha Swamy and Rahul Ray and has published in prestigious journals such as Journal of Clinical Oncology, Biochemistry and Cancer Research.

In The Last Decade

Nancy Paz

21 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Paz United States	9	226	201	149	124	93	21	539
Bai Ji China	12	160 0.7×	273 1.4×	215 1.4×	80 0.6×	154 1.7×	36	618
Lele Zhang China	6	244 1.1×	231 1.1×	143 1.0×	89 0.7×	64 0.7×	13	632
Hendrica A.J.M. Prevoo Netherlands	15	244 1.1×	194 1.0×	276 1.9×	119 1.0×	76 0.8×	18	657
Le-Cun Xu United States	8	246 1.1×	226 1.1×	59 0.4×	63 0.5×	80 0.9×	12	608
Sanjay Thamake United States	15	235 1.0×	334 1.7×	142 1.0×	161 1.3×	136 1.5×	28	791
Fangjing Wang United States	15	114 0.5×	184 0.9×	131 0.9×	52 0.4×	85 0.9×	21	669
Rekha Samuel United States	9	261 1.2×	280 1.4×	114 0.8×	67 0.5×	48 0.5×	9	706
Yamin Zhang China	13	139 0.6×	344 1.7×	79 0.5×	67 0.5×	50 0.5×	26	561
Chun-Ying Qu China	14	104 0.5×	271 1.3×	83 0.6×	97 0.8×	45 0.5×	25	563
Jinxiang Tan China	14	208 0.9×	429 2.1×	129 0.9×	81 0.7×	51 0.5×	21	818

Countries citing papers authored by Nancy Paz

Since Specialization

Citations

This map shows the geographic impact of Nancy Paz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Paz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Paz more than expected).

Fields of papers citing papers by Nancy Paz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Paz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Paz. The network helps show where Nancy Paz may publish in the future.

Co-authorship network of co-authors of Nancy Paz

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Paz. A scholar is included among the top collaborators of Nancy Paz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Paz. Nancy Paz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klinz, Stephan G., Shannon C. Leonard, Nancy Paz, et al.. (2018). DNA damage with liposomal irinotecan (nal-IRI) in pancreatic cancer xenografts: Multimodal analysis of deposition characteristics.. Journal of Clinical Oncology. 36(15_suppl). e16205–e16205. 2 indexed citations

Huang, Huang‐Chiao, Imran Rizvi, Sriram Anbil, et al.. (2017). Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery. Cancer Research. 78(2). 558–571. 84 indexed citations

Leonard, Shannon C., Helen Lee, Daniel F. Gaddy, et al.. (2017). Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer. Anti-Cancer Drugs. 28(10). 1086–1096. 25 indexed citations

Leonard, Shannon C., Helen Lee, Stephan G. Klinz, et al.. (2017). P1.07-006 Preclinical Support for Evaluation of Irinotecan Liposome Injection (nal-IRI, MM-398) in Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S699–S699. 2 indexed citations

Klinz, Stephan G., Jinzi Zheng, Raquel De Souza, et al.. (2016). Abstract B47: Nanoliposomal irinotecan (nal-IRI) is an active treatment and reduces hypoxia as measured through longitudinal imaging using [18F]FAZA-PET in an orthotopic patient-derived model of pancreatic cancer. Cancer Research. 76(24_Supplement). B47–B47. 1 indexed citations

Gaddy, Daniel F., Helen Lee, Nancy Paz, et al.. (2016). Abstract 4830: Preclinical anti-tumor activity of nanoliposomal irinotecan (Nal-IRI, MM-398) + 5-FU + oxaliplatin in pancreatic cancer. Cancer Research. 76(14_Supplement). 4830–4830. 1 indexed citations

Kang, Min H., Jing Wang, Monish Ram Makena, et al.. (2015). Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression. Clinical Cancer Research. 21(5). 1139–1150. 85 indexed citations

Kalra, Ashish, Jaeyeon Kim, Stephan G. Klinz, et al.. (2014). Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion. Cancer Research. 74(23). 7003–7013. 151 indexed citations

Kalra, Ashish, Joseph A. Spernyak, Jaeyeon Kim, et al.. (2014). Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI). Cancer Research. 74(19_Supplement). 2065–2065. 13 indexed citations

10.

Chan, Daniel C., Ashish Kalra, Zhiyong Zhang, et al.. (2014). Abstract 4626: Evaluating the pharmacodynamics and pharmacokinetic effects of MM-398, a nanoliposomal irinotecan (nal-IRI) in subcutaneous xenograft tumor models of human squamous cell carcinoma and small cell lung cancers. Cancer Research. 74(19_Supplement). 4626–4626. 1 indexed citations

11.

Kalra, Ashish, Jaeyeon Kim, Stephan G. Klinz, et al.. (2013). Abstract 5622: The tumor microenvironment modulates the delivery and activation of liposomal encapsulated irinotecan, MM-398.. Cancer Research. 73(8_Supplement). 5622–5622. 1 indexed citations

12.

Klinz, Stephan G., Jinzi Zheng, Raquel De Souza, et al.. (2013). Abstract C293: Irinotecan sucrosofate liposome injection, MM-398, demonstrates superior activity and control of hypoxia as measured through longitudinal imaging using [18F]FAZA PET compared to free irinotecan in a colon adenocarcinoma xenograft model.. Molecular Cancer Therapeutics. 12(11_Supplement). C293–C293. 3 indexed citations

13.

Kalra, Ashish, Stephan G. Klinz, Nancy Paz, et al.. (2012). Abstract 5696: Evaluating determinants for enhanced activity of MM-398/PEP02; a novel nanotherapeutic encapsulation of irinotecan (CPT-11). Cancer Research. 72(8_Supplement). 5696–5696. 1 indexed citations

14.

Kim, Jaeyeon, Eliel Bayever, Clet Niyikiza, et al.. (2012). Abstract A6: Sustained intratumoral activation of MM-398 results in superior activity over irinotecan demonstrated by using a systems pharmacology approach. Cancer Research. 72(13_Supplement). A6–A6. 2 indexed citations

15.

Paz, Nancy, Clet Niyikiza, Ulrik B. Nielsen, et al.. (2012). Abstract A63: MM-398/PEP02, a novel liposomal formulation of irinotecan, demonstrates stromal-modifying anticancer properties.. Tumor Biology. A63–A63. 2 indexed citations

16.

Klinz, Stephan G., Nancy Paz, Ashish Kalra, et al.. (2011). Abstract C207: Identifying differential mechanisms of action for MM-398/PEP02, a novel nanotherapeutic encapsulation of irinotecan.. Molecular Cancer Therapeutics. 10(11_Supplement). C207–C207. 1 indexed citations

17.

Izmailova, Elena S., Nancy Paz, Herlen Alencar, et al.. (2006). Use of molecular imaging to quantify response to IKK‐2 inhibitor treatment in murine arthritis. Arthritis & Rheumatism. 56(1). 117–128. 39 indexed citations

18.

Anderson, Karen S., Michael Fitzgerald, Michelle DuPont, et al.. (2006). Mice deficient in PKC theta demonstrate impairedin vivoT cell activation and protection from T cell-mediated inflammatory diseases. Autoimmunity. 39(6). 469–478. 59 indexed citations

19.

Swamy, Narasimha, Wenrong Xu, Nancy Paz, et al.. (2000). Molecular Modeling, Affinity Labeling, and Site-Directed Mutagenesis Define the Key Points of Interaction between the Ligand-Binding Domain of the Vitamin D Nuclear Receptor and 1α,25-Dihydroxyvitamin D₃. Biochemistry. 39(40). 12162–12171. 28 indexed citations

20.

James, David A., Narasimha Swamy, Nancy Paz, Robert N. Hanson, & Rahul Ray. (1999). Synthesis and estrogen receptor binding affinity of a porphyrin-estradiol conjugate for targeted photodynamic therapy of cancer. Bioorganic & Medicinal Chemistry Letters. 9(16). 2379–2384. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact